Contribution of the cyclin-dependent kinase inhibitor p27KIP1 to the confluence-dependent resistance of HT29 human colon carcinoma cells
Open Access
- 31 August 1998
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 77 (5), 796-802
- https://doi.org/10.1002/(sici)1097-0215(19980831)77:5<796::aid-ijc20>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cellsOncogene, 1997
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agentsNature Medicine, 1996
- Mice Lacking p27 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary TumorsCell, 1996
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cellsCancer Letters, 1994
- Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signalsCell, 1994
- Drug and radiation resistance in spheroids: cell contact and kineticsCancer and Metastasis Reviews, 1994
- Confluence‐dependent resistance in human colon cancer cells: Role of reduced drug accumulation and low intrinsic chemosensitivity of resting cellsInternational Journal of Cancer, 1992
- In vitro enhancement of cis-platinum antitumor activity by caffeine and pentoxifylline in a human ovarian cell lineGynecologic Oncology, 1991